Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Long-term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation

NCT01230762 is registered in ClinicalTrials.gov with Alza Corporation, DE, USA as lead sponsor.

NCT NCT01230762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01230762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Long-term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation
Lead sponsor
Alza Corporation, DE, USA
Phase
Phase 3
Overall status
Completed
Start date
Not reported
Completion date
April 30, 2005
Enrollment
1,774 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ejaculation, erectile dysfunction, sexual dysfunction